Prime Medicine Inc (NASDAQ:PRME) currently has a daily average trading volume of 1.37M but it saw 1199334 shares traded in last market. With a market cap of 478.92M USD, the company’s current market price of $3.99 came falling about -10.54 while comparing to the previous closing price of $4.46. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.86 and as low as $3.28. In the recent trading on the day, stock has struck highest price mark of $3.93 while lowest mark touched by it was $4.48.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the H.C. Wainwright which initiated the stock as “Buy” in its note to investors issued on May 20, 2024, recommending a price target of $10 for it. Citigroup upgraded its recommendation for the stock as a “Buy” from “Neutral” on May 16, 2024 while assigning a price target of $10. Chardan Capital Markets also issued its recommendations for the stock as it initiated the price target for the stock is $17.
Over the week, PRME’s stock price is moving 0.76% up while it is 14.00% when we observe its performance for the past one month. Year-to-date it is -54.97% down and over the past year, the stock is showing a downside performance of -42.92%.
Currently, Prime Medicine Inc’s total number of outstanding shares is 97.38M. Company’s return on investment (ROI) stands at -93.34% and return on equity (ROE) at -99.58%. Stock’s beta reads 2.17. Stock has a price to book (P/B) ratio of 2.44 while price to sale or P/S ratio amounts to 811.73. Its return on asset (ROA) is -80.45% on average.
